The mechanism behind parthenolide selectivity towards cancer stem cells is not completely understood, but it is believed that the reason lies in its ability to target multiple major pathways required for cancer stem cell survival and self-renewal, such as MAPK, JAK/STAT, PI3K and NF-κB signaling [524,537]. This evidence concerns the gene NFKB1 and cancer.